On April 28, a shareholder of Asymchem Laboratories transferred shares from Citibank to Morgan Stanley Hong Kong Securities, with a total transfer value of HK$177 million, accounting for 6.06% of the company's holdings. Separately, Asymchem Laboratories reported its first-quarter 2026 financial results, showing revenue of approximately RMB 1.802 billion, a year-on-year increase of 16.91%. Net profit attributable to shareholders was about RMB 304 million, down 6.82% compared to the same period last year. After excluding non-recurring items, net profit was approximately RMB 272 million, reflecting a decrease of 10.88% year-on-year. Basic earnings per share stood at RMB 0.84.
Comments